Lofty Laboratories

India Founded: 2005 • Age: 21 yrs
Serves as a CDMO focused on pharmaceutical intermediates manufacturing.

About Lofty Laboratories

Lofty Laboratories is a Healthcare company based in India founded in 2005. It serves as a CDMO focused on pharmaceutical intermediates manufacturing. It operates on a B2B model. The company has 34 employees. Its Indian entity Lofty Laboratories Private Limited reported revenue of β‚Ή29.82 Cr. Its focus areas include Pharmaceuticals, Manufacturing and CDMO Services. Its competitors include Viyash, Inventys, Blue Jet Healthcare, Ami organics and Aparna Pharmaceuticals and 4 more; 4 of its 9 listed competitors have raised funding.

Company details

Lofty Laboratories serves as a cdmo focused on pharmaceutical intermediates manufacturing, focusing on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and cdmo services. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.

  • Headquarters India
  • Employees 34
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website loftylabs.in
  • Legal Name Lofty Laboratories Private Limited
  • Date of Incorporation 01 Jan, 2004
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Annual Revenue
    ₹29.82 Cr

    FY 2025 · +119% YoY

  • Net Profit
    ₹1.47 Cr

    FY 2025 · 5% margin

  • EBITDA
    ₹3.43 Cr

    FY 2025 · 12% margin

  • Employee Count
    34

Board of directors of Lofty Laboratories Private Limited (Lofty Laboratories)

Lofty Laboratories Private Limited is the primary company behind Lofty Laboratories. The board of Lofty Laboratories Private Limited currently have 3 directors; the longest-serving is Anurag Reddy Vanamareddy, appointed in 2023. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Anurag Reddy Vanamareddy
DIN 09360495
Director10 May 20233 yrs 5 moLofty Laboratories Private Limited
Pamulapati Reddy Vijaykumar
DIN 08737911
Director10 May 20233 yrs 5 moLofty Laboratories Private Limited
Arunkumar Dadi
DIN 11381975
Director30 Jan 20268 moLofty Laboratories Private Limited

Financials of Lofty Laboratories

Figures of Lofty Laboratories Private Limited, the primary company behind Lofty Laboratories, for FY 2025. Revenue was ₹29.82 Cr (+119% year on year). Net profit was ₹1.47 Cr (5% margin). EBITDA was ₹3.43 Cr (12% margin). Revenue has grown at a compounded annual rate of -1% over three years and +5% over five years.

  • ₹29.82 CrRevenue · FY 2025 · +119% YoY
  • ₹1.47 CrNet profit · 5% margin
  • ₹3.43 CrEBITDA · 12% margin
  • ₹1.25 CrPaid-up capital
  • 34Employees (provident fund records)
  • -1%Revenue CAGR, 3 years
  • +5%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Lofty Laboratories Private Limited are on its company page.

Premium access

Detailed financial statements for Lofty Laboratories

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Lofty Laboratories

Lofty Laboratories has 9 listed competitors in our database, 4 of them funded. They include Viyash, Inventys, Blue Jet Healthcare, Ami organics and Aparna Pharmaceuticals, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
viyash.com2019Hyderabad, India$120.02M277
APIs and intermediates are manufactured by Viyash as a CDMO.
inventys.in2005Mumbai, India$64.34M219
Actives, advanced intermediates, and specialty chemicals are custom manufactured.
bluejethealthcare.com1969Mumbai, India–476
CDMO focused on manufacturing, supplier, and development of intermediates & APIs
amiorganics.com2007Surat, India–4
Advanced API intermediates are manufactured for pharmaceutical use.
aparnapharma.com2008Hyderabad, India$674,328328
API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO.
dudechem.com2019Berlin, Germany$6.98M–
CDMO focused on manufacturing of APIs and intermediates
hindyslab.com2007Hyderabad, India–285
Manufactures and exports pharmaceutical intermediates for global markets.
hsbiopharm.com2004Hangzhou, China––
APIs, intermediates, and finished dosage forms are manufactured.
enantilabs.com2007Hyderabad, India–178
Enanti Labs produces pharmaceutical intermediates and APIs in India with quality focus.
Premium access

Detailed competitors of Lofty Laboratories

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Pharmaceuticals & Distribution

10 companies that operate in the same segment as Lofty Laboratories (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 213.52 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Lofty Laboratories

Lofty Laboratories was founded in 2005.

Lofty Laboratories is headquartered in India.

Lofty Laboratories has 34 employees.

The primary company behind Lofty Laboratories, Lofty Laboratories Private Limited, reported revenue of β‚Ή29.82 Cr for FY 2025, up 119% year on year.

Lofty Laboratories serves as a cdmo focused on pharmaceutical intermediates manufacturing, focusing on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and cdmo services. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.

Lofty Laboratories's top competitors include Inventys, Viyash and Blue Jet Healthcare.

Lofty Laboratories operates through Lofty Laboratories Private Limited.

The legal entities of Lofty Laboratories currently have 3 directors, including Anurag Reddy Vanamareddy, Pamulapati Reddy Vijaykumar, Arunkumar Dadi.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available